Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1995-1-26
|
pubmed:abstractText |
Recent studies have provided convincing evidence to add to a number of earlier observations suggesting that the rapid intracellular degradation of mammalian ornithine decarboxylase (ODC) is further accelerated by the action of ornithine decarboxylase antizyme (ODC-Az), a polyamine-induced protein. However, the mechanism whereby ODC-Az exerts its effect in this proteolytic process is mostly unknown. Here, by using reticulocyte-lysate-based synthesis and degradation systems, we demonstrate that interaction of ODC-Az with ODC results in two related outcomes: (a) ODC is inactivated as a result of its monomerization, and (b) ODC degradation is dramatically accelerated. While ODC inactivation requires the integrity of the ODC-Az binding site of ODC and the ODC binding site of ODC-Az, acceleration in ODC degradation also requires the previously characterized carboxyl-terminal destabilizing segment of ODC and a specific segment of ODC-Az that may be functionally distinct from that required for ODC binding. Interestingly, an active ODC variant with a mutant ODC-Az binding site is stable under basal degradation conditions. This, together with the ability of anti-(ODC-Az) antibody to specifically inhibit the basal degradation of ODC in the lysate, suggests that ODC-Az is an essential general mediator of ODC degradation. Based on these observations, we propose a model for the degradation of ODC which always require interaction with antizyme.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Macromolecular Substances,
http://linkedlifedata.com/resource/pubmed/chemical/Ornithine Decarboxylase,
http://linkedlifedata.com/resource/pubmed/chemical/Polyamines,
http://linkedlifedata.com/resource/pubmed/chemical/Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/ornithine decarboxylase antizyme
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0014-2956
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
226
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
547-54
|
pubmed:dateRevised |
2007-7-23
|
pubmed:meshHeading |
pubmed-meshheading:8001569-Amino Acid Sequence,
pubmed-meshheading:8001569-Animals,
pubmed-meshheading:8001569-Binding Sites,
pubmed-meshheading:8001569-Macromolecular Substances,
pubmed-meshheading:8001569-Mice,
pubmed-meshheading:8001569-Molecular Sequence Data,
pubmed-meshheading:8001569-Mutagenesis, Site-Directed,
pubmed-meshheading:8001569-Ornithine Decarboxylase,
pubmed-meshheading:8001569-Point Mutation,
pubmed-meshheading:8001569-Polyamines,
pubmed-meshheading:8001569-Proteins,
pubmed-meshheading:8001569-Reticulocytes,
pubmed-meshheading:8001569-Structure-Activity Relationship
|
pubmed:year |
1994
|
pubmed:articleTitle |
A unified pathway for the degradation of ornithine decarboxylase in reticulocyte lysate requires interaction with the polyamine-induced protein, ornithine decarboxylase antizyme.
|
pubmed:affiliation |
Department of Molecular Genetics and Virology, Weizmann Institute of Science, Rehovot, Israel.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|